Efficacy of Immune Checkpoint Inhibitors in Metastatic Melanoma (MM) Patients with Concurrent Chronic Lymphocytic Leukemia (CLL)

被引：0
|
作者：
Guerra, Veronica [1 ]
Ologun, Gabriel [2 ]
Haydu, Lauren [2 ]
Keung, Emily [2 ]
Burton, Elizabeth [2 ]
Tawbi, Hussein [3 ]
Davis, Michael [3 ]
Wargo, Jennifer [2 ]
Ferrajoli, Alessandra [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷
关键词：
chronic lymphocytic leukemia; CLL; melanoma; immune checkpoint inhibitors; nivolumab; ipilimumab; pembrolizumab;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CLL-229
引用
收藏
页码：S225 / S225
页数：1
相关论文
共 50 条
  • [41] Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma
    Gide, Tuba N.
    Wilmott, James S.
    Scolyer, Richard A.
    Long, Georgina V.
    CLINICAL CANCER RESEARCH, 2018, 24 (06) : 1260 - 1270
  • [42] Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic Leukemia
    Taghiloo, Saeid
    Asgarian-Omran, Hossein
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (10) : 1408 - 1438
  • [43] Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic Leukemia
    Saeid Taghiloo
    Hossein Asgarian-Omran
    Current Treatment Options in Oncology, 2023, 24 : 1408 - 1438
  • [44] Efficacy and Safety Profiles of Surgical Resection in Patients with Metastatic Gynecologic Melanoma on Immune Checkpoint Inhibitors: A Retrospective Cohort Study
    Naderi-Azad, S.
    BRITISH JOURNAL OF SURGERY, 2021, 108
  • [45] Concurrent Radiosurgery and Immune Checkpoint Inhibition Improving Regional Intracranial Control for Patients With Metastatic Melanoma
    Murphy, Blair
    Walker, Joshua
    Bassale, Solange
    Monaco, Debra
    Jaboin, Jerry
    Ciporen, Jeremy
    Taylor, Matthew
    Kubicky, Charlotte Dai
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (03): : 253 - 257
  • [46] The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors
    Dravillas, Caroline E.
    Coleman, Samuel S.
    Hoyd, Rebecca
    Caryotakis, Griffin
    Denko, Louis
    Chan, Carlos H. F.
    Churchman, Michelle L.
    Denko, Nicholas
    Dodd, Rebecca D.
    Eljilany, Islam
    Hardikar, Sheetal
    Husain, Marium
    Ikeguchi, Alexandra P.
    Jin, Ning
    Ma, Qin
    McCarter, Martin D.
    Osman, Afaf E. G.
    Robinson, Lary A.
    Singer, Eric A.
    Tinoco, Gabriel
    Ulrich, Cornelia M.
    Zakharia, Yousef
    Spakowicz, Daniel
    Tarhini, Ahmad A.
    Tan, Aik Choon
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (08): : 1978 - 1990
  • [47] Monitoring of patients with metastatic melanoma treated with immune checkpoint inhibitors using PET–CT
    Antonia Dimitrakopoulou-Strauss
    Cancer Immunology, Immunotherapy, 2019, 68 : 813 - 822
  • [48] The experience of immune checkpoint inhibitors in Chinese patients with metastatic melanoma: a retrospective case series
    Xizhi Wen
    Ya Ding
    Jingjing Li
    Jingjing Zhao
    Ruiqing Peng
    Dandan Li
    Baoyan Zhu
    Yao Wang
    Xing Zhang
    Xiaoshi Zhang
    Cancer Immunology, Immunotherapy, 2017, 66 : 1153 - 1162
  • [49] Immune and metabolic architecture of TIME in metastatic acral melanoma patients treated with checkpoint inhibitors
    Ekmekcioglu, Suhendan
    Ludford, Kaysia
    Cho, SungNam
    Eddine-Bentebibel, Salah
    Basi, Akshay V.
    Abdel-Wahab, Reham
    Wani, Khalida M.
    Abdel-Wahab, Noha
    Burks, Jared K.
    Diab, Adi
    CANCER IMMUNOLOGY RESEARCH, 2025, 13 (02)
  • [50] Impact of clinicopathological characteristics on survival in patients treated with immune checkpoint inhibitors for metastatic melanoma
    Zhao, Bin
    Zhao, Hong
    Zhao, Jiaxin
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (01) : 169 - 177
12345